|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2004-6-16
|
|
pubmed:abstractText |
Osteoprotegerin (OPG) is a glycoprotein that inhibits osteoclast differentiation and activity. OPG-deficient mice develop severe osteoporosis and medial arterial calcification. The expression of OPG is detected in early atherosclerotic lesions in non-uraemic patients. We examined whether serum OPG is associated with aortic calcification in haemodialysis patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0931-0509
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
19
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1886-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15128884-Adult,
pubmed-meshheading:15128884-Aged,
pubmed-meshheading:15128884-Aged, 80 and over,
pubmed-meshheading:15128884-Aortic Diseases,
pubmed-meshheading:15128884-Calcinosis,
pubmed-meshheading:15128884-Female,
pubmed-meshheading:15128884-Glycoproteins,
pubmed-meshheading:15128884-Humans,
pubmed-meshheading:15128884-Male,
pubmed-meshheading:15128884-Middle Aged,
pubmed-meshheading:15128884-Osteoprotegerin,
pubmed-meshheading:15128884-Receptors, Cytoplasmic and Nuclear,
pubmed-meshheading:15128884-Receptors, Tumor Necrosis Factor,
pubmed-meshheading:15128884-Renal Dialysis,
pubmed-meshheading:15128884-Severity of Illness Index
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Serum osteoprotegerin levels and the extent of vascular calcification in haemodialysis patients.
|
|
pubmed:affiliation |
Department of Medicine, Kidney Center, Tokyo Women's Medical University, Tokyo, Japan. nitta@kc.twmu.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
